Dopamine in Parkinson's Disease and Schizophrenia

Neurologist and Professor at the University of Malaya, Kuala Lumpur, Malaysia

Professor and Chair of the Department of Child and Adolescent Psychiatry, Charité University Medicine, Berlin, Germany and also Professor of Psychiatry at The Zucker School of Medicine at Hofstra/Northwell, New York, USA.

In this video, Professors Shen-Yang Lim and Christoph Correll discuss the crucial role of dopamine in both Parkinson’s disease and Schizophrenia.

Learn how dopamine deficiency leads to motor symptoms in Parkinson’s disease and how excessive dopaminergic activity contributes to psychosis in Schizophrenia. The discussion covers the evolution of treatments, including levodopa for Parkinson’s disease, and postsynaptic dopamine blockers for Schizophrenia. The conversation also touches on side effects, and parallels between these two brain disorders.

Learn more about Parkinson’s Disease

Learn more about Schizophrenia